QuantRx holds a significant position in Genomics USA, Inc., a Chicago-based developer of microarray technology for DNA testing.
QuantRx has a technology license agreement with P&G giving QuantRx access to P&G technology for incorporation into the QuantRx PAD portfolio of products, specifically hemorrhoid treatment products.
QuantRx has corporate offices in Doylestown, Pennsylvania. The QuantRx research and development center is in Portland, Oregon. The Company holds significant positions in FluoroPharma, Inc., a Boston-based molecular imaging company, and Genomics USA, Inc., a Chicago-based developer of microarray technology for DNA testing.
Pre-manufacturing takes place at our Portland R&D facility. Full-scale manufacturing is outsourced to a number of companies in China.
A component of the QuantRx business strategy is to concentrate on what the Company knows and does best -- the development of diagnostic technology platforms and the commercialization of related products. As such, we outsource related activities such as manufacturing and distribution. Most of the individuals under the employ of QuantRx and its affiliate companies are accomplished scientists and medical experts. We also contract a number of individuals in specialized scientific areas of expertise.